Apotex re-enters market with authorized Paxil CR generic

WESTON, Fla. — Apotex on Thursday announced that it would be re-entering the market with its authorized generic version of Paxil CR (paroxetine controlled-release) tablets. 

 

Apotex’s authorized generic will be available in 12.5-, 25- and 37.5-mg dosage strengths. The drug had about $126 million in sales for the 12 months ended June 2016, according to IMS Health.